MediciNova reaches 200-patient enrollment in NIH-funded ALS study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. FTNT
4. QCOM
5. ARM
6. SBUX
7. TENB
8. CVNA
9. CMG
10. EQIX

Go back to MediciNova reaches 200-patient enrollment in NIH-funded ALS study
Medicinova, Inc. (NASDAQ: MNOV) Delayed: 1.34 +0.05 (3.88%)
Previous Close $1.29    52 Week High $10.16 
Open $1.29    52 Week Low $2.91 
Day High $1.35    P/E N/A 
Day Low $1.29    EPS $-0.41 
Volume 42,909